Role of blood biomarkers in spontaneous intracerebral hemorrhage – a prospectively studied cohort of patients

Flaherty ML, Haverbusch M, Sekar P et al. Long-term mortality after intracerebral hemorrhage. Neurology 2006; 66: 1182–1186.

Senn R, Elkind MS, Montaner J et al. Potential role of blood biomarkers in the management of nontraumatic intracerebral hemorrhage. Cerebrovasc Dis 2014; 38(6): 395–409.

Di Napoli M, Godoy DA, Campi V et al. C-reactive protein in intracerebral hemorrhage: time course, tissue localization, and prognosis. Neurology 2012; 79: 690–699.

Misra S, Kumar A, Ram S et al. Role of copeptin as a biomarker for predicting outcome after intracerebral hemorrhage: a prospective cohort study. Abstract. J Neurol Sci 2017; 381: 622.

Drucker E, Krapfenbauer K. Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA J 2013; 4(1): 7.

Abilleira S, Montaner J, Molina CA et al. Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage. J Neurosurg 2003; 99: 65–70.

Silva Y, Leira R, Tejada J et al. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke 2005; 36: 86–91.

Glushakova OY, Glushakov AV, Miller ER et al. Biomarkers for acute diagnosis and management of stroke in neurointensive care units. Brain Circ 2016; 2: 28–47.

Hu YY, Dong XQ, Yu WH et al. Change in plasma S100B level after acute spontaneous basal ganglia hemorrhage. Shock 2010; 33: 134–140.

Kubiak C, Mohamed W, Bhattacharya P. Admission blood glucose predicts high hematoma volume in intracerebral hemorrhage. Neurology 2013; 80: P05.229.

Bakradze E, McCullough LD, Staff I, Nouh A. Vitamin D deficiency correlates with stroke severity on presentation in intracerebral hemorrhage [abstract]. Stroke 2016; 47: ATP375.

Agnihotri S, Czap A, Staff I et al. Peripheral leukocyte counts and outcomes after intracerebral hemorrhage. J Neuroinflammation 2011; 8: 160.

Di Napoli M, Godoy DA, Campi V et al. C-reactive protein level measurement improves mortality prediction when added to the spontaneous intracerebral hemorrhage score. Stroke 2011; 42: 1230–1236.

Newman CG. Clarification of abc/2 rule for ICH volume. Stroke 2007; 38: 862.

Delgado P, Alvarez Sabin J, Santamarina E et al. Plasma S100B level after acute spontaneous intracerebral hemorrhage. Stroke 2006; 37: 2837–2839.

Castellazzi M, Tamborino C, De Santis G et al. Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage. Acta Neurochir Suppl. 2010; 106: 137–140.

Kreisel SH, Stroick M, Griebe M et al. True effects or bias? MMP-2 and MMP-9 serum concentrations after acute stroke. Cerebrovasc Dis 2016; 42: 352–360.

Jonsson A, Hjalmarsson C, Falk P et al. Levels of matrix metalloproteinases differ in plasma and serum – aspects regarding analysis of biological markers in cancer. Br J Cancer 2016; 115(6): 703–706.